BIOCRYST PHARMACEUTICALS, INC. Increase (Decrease) in Receivables
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Increase (Decrease) in Receivables of $1.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2026-06-30 was $1.49M, a 79.68% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2026-03-31 was $474.00K, a 96.61% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2025-12-31 was $15.49M, a 112.36% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2025-09-30 was $17.00K, a 99.49% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2025 was $36.81M, a 62.16% increase from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2024 was $22.70M, a 272.40% increase from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2023 was $6.09M, a 71.61% decline from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2022 was $21.47M, a 3.14% increase from fiscal 2021.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 6 month as first filed | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.96M 10-Q · filed 2026-08-05 | $17.45M derived: sum of 3 quarters · filed 2026-08-05 | $17.47M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $474.00K 10-Q · filed 2026-05-06 | $15.97M derived: sum of 2 quarters · filed 2026-05-06 | $15.98M derived: sum of 3 quarters · filed 2026-05-06 | $23.29M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $15.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.51M derived: sum of 2 quarters · filed 2026-02-26 | $22.82M derived: sum of 3 quarters · filed 2026-08-05 | $36.81M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.33M derived: sum of 2 quarters · filed 2026-08-05 | $21.31M 10-Q · filed 2025-11-04 | $28.61M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $7.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $21.30M 10-Q · filed 2026-08-05 | $28.59M derived: sum of 3 quarters · filed 2026-08-05 | $31.91M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $13.99M 10-Q · filed 2026-05-06 | $21.28M derived: sum of 2 quarters · filed 2026-05-06 | $24.60M derived: sum of 3 quarters · filed 2026-05-06 | $32.85M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.61M derived: sum of 2 quarters · filed 2026-02-26 | $18.86M derived: sum of 3 quarters · filed 2026-02-26 | $22.70M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $11.56M derived: sum of 2 quarters · filed 2025-11-04 | $15.40M 10-Q · filed 2025-11-04 | $18.37M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $8.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $12.09M 10-Q · filed 2025-08-05 | $15.05M derived: sum of 3 quarters · filed 2026-02-26 | $11.21M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $3.84M 10-Q · filed 2025-05-06 | $6.81M derived: sum of 2 quarters · filed 2026-02-26 | $2.97M derived: sum of 3 quarters · filed 2026-02-26 | $11.95M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$873.00K derived: sum of 2 quarters · filed 2026-02-26 | $8.11M derived: sum of 3 quarters · filed 2026-02-26 | $6.09M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $5.14M derived: sum of 2 quarters · filed 2024-11-05 | $3.13M 10-Q · filed 2024-11-05 | $10.77M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | $8.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $6.97M 10-Q · filed 2024-08-06 | $14.61M derived: sum of 3 quarters · filed 2025-02-25 | $16.09M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | -$2.02M 10-Q · filed 2024-05-07 | $5.62M derived: sum of 2 quarters · filed 2025-02-25 | $7.11M derived: sum of 3 quarters · filed 2025-02-25 | $12.40M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | $7.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $9.13M derived: sum of 2 quarters · filed 2025-02-25 | $14.42M derived: sum of 3 quarters · filed 2025-02-25 | $21.47M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $6.78M derived: sum of 2 quarters · filed 2023-11-08 | $13.83M 10-Q · filed 2023-11-08 | $17.07M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $5.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $12.34M 10-Q · filed 2023-08-07 | $15.58M derived: sum of 3 quarters · filed 2024-02-27 | $14.18M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $7.05M 10-Q · filed 2023-05-08 | $10.29M derived: sum of 2 quarters · filed 2024-02-27 | $8.89M derived: sum of 3 quarters · filed 2024-02-27 | $27.60M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.84M derived: sum of 2 quarters · filed 2024-02-27 | $20.56M derived: sum of 3 quarters · filed 2024-02-27 | $20.82M 10-K · filed 2024-02-27 | |
| 2021-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $17.32M derived: sum of 2 quarters · filed 2022-11-04 | $17.58M 10-Q · filed 2022-11-04 | $20.40M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $18.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $18.98M 10-Q · filed 2022-08-05 | $21.80M derived: sum of 3 quarters · filed 2023-02-27 | $23.22M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $261.00K 10-Q · filed 2022-05-09 | $3.08M derived: sum of 2 quarters · filed 2023-02-27 | $4.51M derived: sum of 3 quarters · filed 2023-02-27 | $2.86M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $4.25M derived: sum of 2 quarters · filed 2023-02-27 | $2.60M derived: sum of 3 quarters · filed 2023-02-27 | -$13.90M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$220.00K derived: sum of 2 quarters · filed 2021-11-04 | -$16.72M 10-Q · filed 2021-11-04 | $1.82M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$18.15M 10-Q · filed 2021-08-09 | $399.00K derived: sum of 3 quarters · filed 2022-02-28 | $395.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$16.50M 10-Q · filed 2021-05-07 | $2.04M derived: sum of 2 quarters · filed 2022-02-28 | $2.04M derived: sum of 3 quarters · filed 2022-02-28 | $640.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $18.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $18.54M derived: sum of 2 quarters · filed 2022-02-28 | $17.14M derived: sum of 3 quarters · filed 2022-02-28 | $17.85M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.40M derived: sum of 2 quarters · filed 2020-11-06 | -$695.00K 10-Q · filed 2020-11-06 | $204.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$691.00K 10-Q · filed 2020-08-07 | $208.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.26M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $709.00K 10-Q · filed 2020-05-11 | $1.61M derived: sum of 2 quarters · filed 2021-03-01 | $2.66M derived: sum of 3 quarters · filed 2021-03-01 | -$692.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $899.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.95M derived: sum of 2 quarters · filed 2021-03-01 | -$1.40M derived: sum of 3 quarters · filed 2021-03-01 | -$1.82M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$2.30M derived: sum of 2 quarters · filed 2019-11-08 | -$2.72M 10-Q · filed 2019-11-08 | -$5.59M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-06-30 | -$3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$3.77M 10-Q · filed 2019-08-08 | -$6.64M derived: sum of 3 quarters · filed 2020-03-13 | -$983.00K derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-03-31 | -$423.00K 10-Q · filed 2019-05-09 | -$3.29M derived: sum of 2 quarters · filed 2020-03-13 | $2.37M derived: sum of 3 quarters · filed 2020-03-13 | -$3.87M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2017-12-31 | -$2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $2.79M derived: sum of 2 quarters · filed 2020-03-13 | -$3.45M derived: sum of 3 quarters · filed 2020-03-13 | -$2.65M 10-K · filed 2020-03-13 | |
| 2017-09-30 | $5.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$579.00K derived: sum of 2 quarters · filed 2018-11-08 | $217.00K 10-Q · filed 2018-11-08 | $3.02M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | -$6.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$5.44M 10-Q · filed 2018-08-09 | -$2.64M derived: sum of 3 quarters · filed 2019-03-14 | $1.09M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | $796.00K 10-Q · filed 2018-05-09 | $3.60M derived: sum of 2 quarters · filed 2019-03-14 | $7.33M derived: sum of 3 quarters · filed 2019-03-14 | $2.18M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $6.53M derived: sum of 2 quarters · filed 2019-03-14 | $1.38M derived: sum of 3 quarters · filed 2019-03-14 | $2.52M 10-K · filed 2019-03-14 | |
| 2016-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$1.42M derived: sum of 2 quarters · filed 2017-11-08 | -$275.00K 10-Q · filed 2017-11-08 | -$1.53M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | -$5.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$4.01M 10-Q · filed 2017-08-08 | -$5.26M derived: sum of 3 quarters · filed 2018-03-12 | -$2.06M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | $1.14M 10-Q · filed 2017-05-08 | -$111.00K derived: sum of 2 quarters · filed 2018-03-12 | $3.09M derived: sum of 3 quarters · filed 2018-03-12 | $1.79M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2015-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $1.95M derived: sum of 2 quarters · filed 2018-03-12 | $649.00K derived: sum of 3 quarters · filed 2018-03-12 | -$3.25M 10-K · filed 2018-03-12 | |
| 2015-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $1.90M derived: sum of 2 quarters · filed 2016-11-08 | -$2.00M 10-Q · filed 2016-11-08 | $4.26M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$5.19M 10-Q · filed 2016-08-08 | $1.06M derived: sum of 3 quarters · filed 2017-02-27 | $3.40M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | -$3.90M 10-Q · filed 2016-05-09 | $2.36M derived: sum of 2 quarters · filed 2017-02-27 | $4.70M derived: sum of 3 quarters · filed 2017-02-27 | $2.31M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-31 | $6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $8.59M derived: sum of 2 quarters · filed 2017-02-27 | $6.21M derived: sum of 3 quarters · filed 2017-02-27 | $7.38M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$42.00K derived: sum of 2 quarters · filed 2015-11-06 | $1.12M 10-Q · filed 2015-11-06 | $869.00K derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$1.22M 10-Q · filed 2015-08-07 | $1.22M 10-Q · filed 2014-08-08 | -$1.47M derived: sum of 3 quarters · filed 2016-02-26 | -$7.20M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $1.17M 10-Q · filed 2015-05-08 | $911.00K derived: sum of 2 quarters · filed 2016-02-26 | -$4.82M derived: sum of 3 quarters · filed 2016-02-26 | -$1.04M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2013-12-31 | -$254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$5.99M derived: sum of 2 quarters · filed 2016-02-26 | -$2.21M derived: sum of 3 quarters · filed 2016-02-26 | -$2.45M 10-K · filed 2016-02-26 | |
| 2013-09-30 | -$5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$1.96M derived: sum of 2 quarters · filed 2014-11-07 | -$2.19M 10-Q · filed 2014-11-07 | -$1.40M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $3.54M 10-Q · filed 2014-08-08 | -$3.54M 10-Q · filed 2013-08-08 | $4.33M derived: sum of 3 quarters · filed 2015-03-02 | $3.02M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | -$237.00K 10-Q · filed 2014-05-09 | $557.00K derived: sum of 2 quarters · filed 2015-03-02 | -$759.00K derived: sum of 3 quarters · filed 2015-03-02 | -$1.53M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-12-31 | $794.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$522.00K derived: sum of 2 quarters · filed 2015-03-02 | -$1.29M derived: sum of 3 quarters · filed 2015-03-02 | -$1.27M 10-K · filed 2015-03-02 | |
| 2012-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$2.08M derived: sum of 2 quarters · filed 2013-11-08 | -$2.06M 10-Q · filed 2013-11-08 | -$7.87M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-06-30 | -$769.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$747.00K 10-Q · filed 2013-08-08 | -$6.55M derived: sum of 3 quarters · filed 2014-03-10 | -$10.88M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2012-03-31 | $22.00K 10-Q · filed 2013-05-09 | -$5.78M derived: sum of 2 quarters · filed 2014-03-10 | -$10.11M derived: sum of 3 quarters · filed 2014-03-10 | -$20.21M derived: sum of 4 quarters · filed 2014-03-10 | |
| 2011-12-31 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$10.13M derived: sum of 2 quarters · filed 2014-03-10 | -$20.23M derived: sum of 3 quarters · filed 2014-03-10 | -$24.40M 10-K · filed 2014-03-10 | |
| 2011-09-30 | -$4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$14.43M derived: sum of 2 quarters · filed 2012-11-08 | -$18.59M 10-Q · filed 2012-11-08 | -$13.93M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-06-30 | -$10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$14.27M 10-Q · filed 2012-08-08 | -$9.60M derived: sum of 3 quarters · filed 2013-03-11 | -$4.57M derived: sum of 4 quarters · filed 2013-03-11 | |
| 2011-03-31 | -$4.17M 10-Q · filed 2012-05-08 | $498.00K derived: sum of 2 quarters · filed 2013-03-11 | $5.53M derived: sum of 3 quarters · filed 2013-03-11 | ||
| 2010-12-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $9.70M derived: sum of 2 quarters · filed 2013-03-11 | -$3.50M 10-K · filed 2013-03-11 | ||
| 2010-09-30 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$8.16M 10-Q · filed 2011-11-03 | |||
| 2010-06-30 | -$13.19M 10-Q · filed 2011-08-04 | ||||
| 2009-12-31 | $21.74M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |